ArticleBiochemical pharmacology2022

Development of a biomarker to monitor target engagement after treatment with dihydroorotate dehydrogenase inhibitors.

Michael A Pontikos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.